Tomer Babu

8PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metal cluster chemistryBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 20, 2026
A next-generation multimetal complex induces immunogenic cell death with distinct transcriptomic signatures.

|Aug 12, 2025
Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death.

Tomer Babu, Matthew S Levine, Sourav Acharya

|Jan 08, 2025
Multitargeting Pt(IV) Derivatives of Cisplatin or Oxaliplatin Inhibit Tumor Growth in Mice without Inducing Neuropathic Pain.

Tomer Babu, Ram Pravin Kumar Muthuramalingam, Wei Heng Chng

|Jan 18, 2024
Stepwise optimization of tumor-targeted dual-action platinum(iv)-gemcitabine prodrugs.

Alexander Kastner, Theresa Mendrina, Tomer Babu

|Aug 30, 2023
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.

Amrita Sarkar, Vojtech Novohradsky, Moumita Maji

|Jan 11, 2023
Oral Anticancer Heterobimetallic PtIV -AuI Complexes Show High In Vivo Activity and Low Toxicity.

Tomer Babu, Hiba Ghareeb, Uttara Basu

Pageof 2

Frequent Collaborators

6 joint publications

Dan Gibson

3 joint publications

Subhendu Karmakar

3 joint publications

Valentina Gandin

2 joint publications

Amrita Sarkar